Risk Factors for Tardive Dyskinesia in Patients Taking Antipsychotics
The risk factors for tardive dyskinesia in patients taking antipsychotics include age, comorbid diagnoses, and high medication dosages.
Mood Disorders
Telemedicine Interventions May Improve Comorbid Pain, Mood Symptoms
Automated self-management with collaborative care from a nurse-physician team produced slightly greater improvements in pain and mood symptomsvs automated self-management alone.
No Link Found Between Mood Stabilizer Use, Placenta-Mediated Complications
Anticonvulsant mood stabilizers were not linked to a greater risk for placenta-mediated complications or preterm birth.
Identifying Factors Related to Inpatient Psychiatric Readmissions for Youth
Youth who are readmitted for inpatient psychiatric care share such factors as foster care, comorbid conditions, and prior psychiatric hospitalizations.
Short-Term Benzodiazepines May Improve Information Processing in Acute MDD
Treatment with benzodiazepines for less than 3 months may not decrease the cognitive function of patients with major depressive disorder who are also prescribed antidepressants.
Benzodiazepine Use During Pregnancy Associated With Spontaneous Abortion
An increased risk for spontaneous abortion in early pregnancy was linked to incident exposure to short- and long-acting benzodiazepines.
Microbiota Transfer Therapy Gets Fast-Tracked for ASD Treatment
The FDA has granted Fast Track status to the microbiota transfer therapy, Full-Spectrum Microbiota (FSM), for the treatment of children with autism spectrum disorder.
Nonsurgical Brain Stimulation Beneficial in Major Depressive Episodes
Ten of 18 reviewed treatment strategies linked to higher response versus sham therapy
Analysis Supports Valbenazine’s Efficacy as Treatment for Tardive Dyskinesia
Consistent with primary KINECT 3 study results, supplemental analyses indicate that participants treated with valbenazine had statistically significant improvements in tardive dyskinesia severity.
Three Factors Predict Adverse Psychiatric Events When Using Smoking Cessation Drugs
Anxiety, previous history of suicidal ideation and/or behavior, and race were associated with increased risk of adverse psychiatric events.
